Risa Nishiyama

Risa Nishiyama

Auto-generated profile, based on publicly available information

Risa Nishiyama

Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan 1

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
KIKazuhisa Ishida
Kazuhisa Ishida
KYKaoru Yamada
Kaoru Yamada
RNRisa Nishiyama
Risa Nishiyama
THTadafumi Hashimoto
Tadafumi Hashimoto
INItaru Nishida
Itaru Nishida
TITakeshi Iwatsubo
Takeshi Iwatsubo
Accumulation of tau has been implicated in various neurodegenerative diseases termed tauopathies. Tau is a microtubule-associated protein but is also actively released into the extracellular fluids including brain interstitial fluid and cerebrospinal fluid (CSF). However, it remains elusive whether clearance of extracellular tau impacts tau-associated neurodegeneration. Here, we show that aquaporin-4 (AQP4), a major driver of the glymphatic clearance system, facilitates the elimination of extracellular tau from the brain to CSF and subsequently to deep cervical lymph nodes. Strikingly, deletion of AQP4 not only elevated tau in CSF but also markedly exacerbated phosphorylated tau deposition and the associated neurodegeneration in the brains of transgenic mice expressing P301S mutant tau. The current study identified the clearance pathway of extracellular tau in the central nervous system, suggesting that glymphatic clearance of extracellular tau is a novel regulatory mechanism whose impairment contributes to tau aggregation and neurodegeneration.